Press release
Artificial Intelligence in Drug Discovery Market Report - Revenue to Reach from $1.71 Bn to $8.52 Bn by 2030 - Arizton
According to Arizton's latest research report, the AI in drug discovery market [https://www.arizton.com/market-reports/ai-in-drug-discovery-market] is growing at a CAGR of 30.58% during 2024-2030.To Know More, Click: [https://www.arizton.com/market-reports/ai-in-drug-discovery-market]
Report Summary
Market Size (2030): $8.52 Billion
Market Size (2024): $1.71 Billion
CAGR (2024-2030): 30.58%
Historic Year: 2021-2023
Base Year: 2024
Forecast Year: 2025-2030
Market Segmentation: Application, Therapeutic Area, Drug Type, Technology, End-user, and Geography
Geographical Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa
The global AI in drug discovery market is experiencing rapid growth as artificial intelligence technologies revolutionize the pharmaceutical and biotechnology industries. With the increasing complexity of drug development and the rising costs of traditional discovery processes, AI is becoming a crucial tool in accelerating the development of novel therapies. AI-driven solutions are transforming various stages of drug discovery, from early-stage research to clinical trials, by enhancing efficiency, reducing costs, and enabling the design of more targeted and personalized treatments. The growing adoption of AI platforms is driven by the rising demand to address complex diseases such as cancer, neurodegenerative disorders, and rare genetic conditions. Innovations in machine learning, natural language processing, and data analytics are making AI more accessible and effective in processing vast amounts of data to identify potential drug candidates, optimize drug design, and improve patient outcomes.
North America leads the market, supported by a robust pharmaceutical sector, significant investment in AI R&D, and a growing number of collaborations between tech companies and research organizations. Meanwhile, regions such as Europe and APAC are also seeing rapid adoption, with governments and organizations backing AI initiatives in drug discovery.
Despite challenges such as regulatory hurdles and data privacy concerns, the AI in drug discovery market holds immense promise for transforming drug development, offering faster, more efficient, and cost-effective pathways to new treatments and personalized medicine.
Pharma & Biotech Companies to Hold the Largest Share
Pharma and biotech companies are key end-users of AI in drug discovery, leveraging AI to accelerate drug development, improve predictive accuracy, and reduce costs. AI is integrated into multiple stages of the drug discovery process, including target identification, molecular design, drug repurposing, preclinical and clinical development, and precision medicine. AI tools analyze large genomic datasets to identify potential drug targets, design optimized molecular structures and predict the efficacy and safety of compounds. Additionally, AI supports drug repurposing by identifying new uses for existing drugs and enhances clinical trials by optimizing patient recruitment.
The adoption of AI provides several benefits, including accelerated drug development, cost efficiency, improved success rates, and enhanced innovation. By automating processes and refining candidate selection, AI helps reduce development timelines and costs while improving the chances of clinical success. Leading companies like Pfizer, Novartis, AstraZeneca, and Amgen are integrating AI into their workflows, and smaller biotech firms such as Recursion Pharmaceuticals and Exscientia are also advancing AI-driven drug discovery. Overall, AI is transforming the pharmaceutical industry, enabling faster, more cost-effective drug development and better outcomes for patients.
Europe - The Powerhouse of the AI in Drug Discovery Market
The Europe AI in drug discovery market is growing rapidly, driven by strong research and development infrastructure, collaborative initiatives, and a focus on ethical AI and data privacy. Key countries like Germany, France, and the UK are at the forefront, fostering partnerships between academia, biotech firms, and AI developers. European initiatives such as the Innovative Medicines Initiative and Horizon Europe are accelerating AI adoption in drug discovery, particularly in areas like precision medicine and rare disease treatments. Government support, including funding and favorable policies, is further boosting AI integration in drug discovery processes.
However, challenges remain, such as data fragmentation, limited AI expertise, high implementation costs, and regulatory hurdles. Despite these challenges, the future of AI in drug discovery in Europe looks promising, with advancements in quantum computing and generative AI set to enhance drug development. The region's commitment to ethical AI practices and data privacy ensures responsible innovation, positioning Europe as a leader in AI-driven drug discovery. Addressing data accessibility and talent shortages will be key to unlocking AI's full potential in the market.
Key Players and Strategic Partnerships in the AI-Driven Drug Discovery Market
The AI in drug discovery market is shaped by a combination of established technology giants, pharmaceutical companies, biotech firms, AI-focused startups, and contract research organizations (CROs). These players contribute to the rapid evolution of AI-driven solutions in drug discovery.
Technology Giants: Major companies like IBM Watson Health, Google DeepMind, and NVIDIA are leading the charge with advanced AI platforms tailored for drug discovery. IBM Watson uses natural language processing and machine learning to analyze scientific literature, while Google DeepMind's AlphaFold revolutionizes protein structure prediction, enhancing the identification of potential drug candidates.
Pharmaceutical and Biotech Companies: Leading pharmaceutical firms, including Pfizer, Novartis, Roche, and AstraZeneca, are integrating AI technologies into their R&D pipelines. Partnerships with AI startups, such as AstraZeneca's collaboration with BenevolentAI, are helping to drive innovation, particularly in drug repurposing and target identification.
AI-Focused Startups: Startups like BenevolentAI, Insilico Medicine, Atomwise, Exscientia, and Recursion Pharmaceuticals are at the forefront of AI in drug discovery. These companies develop sophisticated AI algorithms capable of analyzing complex biological data and accelerating drug development.
Contract Research Organizations (CROs): CROs like Charles River Laboratories and WuXi AppTec are incorporating AI to enhance the efficiency of drug discovery projects, offering AI-driven services to pharmaceutical and biotech companies.
Strategic Partnerships and Investments: Collaboration is a key trend in this market, with pharmaceutical companies partnering with AI providers to enhance their drug discovery capabilities. Notable partnerships include Pfizer and IBM Watson, Sanofi and Exscientia, and GSK's investment in AI companies like Insilico Medicine. Strategic investments are fueling further growth, with venture capital and corporate investors supporting AI-focused startups such as Atomwise and BenevolentAI.
Buy this Research @ https://www.arizton.com/market-reports/ai-in-drug-discovery-market
Key Company Profiles
* Atomwise
* Amazon Web Services (AWS)
* BenevolentAI
* IBM
* Insilico Medicine
* Microsoft
* NVIDIA
* Recursion Pharmaceuticals
* AbCellera
* Aitia
* BenchSci
* BioSymetrics
* BPGbio
* Centella
* Envisagenics
* EVAXION Biotech A/S
* Iktos
* Illumina
* insitro
* Merck KGaA
* Model Medicine
* NuMedii
* Owkin
* Predictive Oncology
* Relay Therapeutics
* Standigm
* Valo Health
* Verge Genomics
* XtalPi
Market Segmentation
Application
* Drug Repurposing
* Drug Screening
* Drug Design & Optimization
* Others
Therapeutic Area
* Oncological Disorders
* CNS Disorders
* Infectious Diseases
* Immunological Disorders
* Cardiovascular Disorders
* Gastrointestinal Disorders
* Others
Drug Type
* Small Molecule
* Biologics
* Segmentation by Technology
* Machine Learning (ML)
* Deep Learning
* Natural Language Processing (NLP)
* Others
End-user
* Pharma & Biotech Companies
* Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs)
* Others
Geography
North America
* The U.S.
* Canada
Europe
* Germany
* The U.K.
* Switzerland
* France
* Italy
* Spain
* Netherlands
APAC
* China
* Japan
* India
* South Korea
* Australia
Latin America
* Brazil
* Mexico
* Argentina
* Colombia
Middle East & Africa
* Turkey
* South Africa
* Saudi Arabia
* The UAE
Key Questions Answered in the Report:
How big is the global AI in drug discovery market?
What is the growth rate of the global AI in the drug discovery market?
Which region dominates the global AI in drug discovery market share?
What are the significant trends in AI in drug discovery industry?
Who are the key players in the global AI in the drug discovery market?
Check Out Some of the Top Selling Reports of Your Interest:
Global AI in Healthcare Market - Focused Insight 2024-2029
[https://www.arizton.com/market-reports/healthcare-artificial-intelligence-market]
Global AI in Medical Imaging Market - Focused Insights 2024-2029
[https://www.arizton.com/market-reports/artificial-intelligence-in-medical-imaging-market]
Why Arizton?
100%Customer Satisfaction
24x7availability - we are always there when you need us
200+Fortune 500 Companies trust Arizton's report
80%of our reports are exclusive and first in the industry
100%more data and analysis
1500+reports published till date
Post-Purchase Benefit
* 1hr of free analyst discussion
* 10% off on customization
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=artificial-intelligence-in-drug-discovery-market-report-revenue-to-reach-from-171-bn-to-852-bn-by-2030-arizton]
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/ai-in-drug-discovery-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence in Drug Discovery Market Report - Revenue to Reach from $1.71 Bn to $8.52 Bn by 2030 - Arizton here
News-ID: 3828560 • Views: …
More Releases from ABNewswire

Salento Steakhouse at Silverleaf is quickly becoming one of St. Augustine's most …
St. Augustine, FL & St. Johns, FL - In under a year, Salento Steakhouse has quickly established itself as the premier new steakhouse in St. Augustine, FL [https://www.google.com/maps/place/Salento+Steakhouse+at+Silverleaf/@30.0169024,-81.5091562,15z/data=!4m6!3m5!1s0x88e42d002748765d:0x18ac6b1c1f84e34!8m2!3d30.0169024!4d-81.5091562!16s%2Fg%2F11v_03hbp5!5m1!1e4?entry=tts&g_ep=EgoyMDI0MDgyMS4wKgBIAVAD]! Nestled in the thriving Silverleaf community, which spans both St. Augustine and St. Johns, Salento has captivated diners with its unique fusion of Colombian-inspired flavors, exceptional service, and an outstanding selection of premium steaks.
Salento Steakhouse offers a culinary experience that celebrates Colombia's…

Total Access: Revolutionizing Construction Equipment Hire in New Zealand
Total Access is setting new standards as the construction industry continues to demand reliable, innovative, and high-performance equipment. Recognized as the top construction equipment hire company in New Zealand, Total Access is revolutionizing access solutions with an extensive fleet of cutting-edge machinery, industry-leading expertise, and a commitment to safety and efficiency.
For over 12 years, Total Access has been the trusted partner for construction firms, industrial contractors, and maintenance professionals seeking…

EspejoBanoLED Revolutionizes Bathroom Elegance with Premium LED Mirrors in Spain
Homeowners and interior designers across Spain can now elevate their bathroom spaces with high-quality, stylish, and energy-efficient LED bathroom mirrors, thanks to EspejoBanoLED.es. Specializing in modern and functional mirror solutions, the company has emerged as the go-to destination for those seeking to enhance their bathrooms with the perfect balance of aesthetics and practicality.
With an exclusive collection of illuminated vanity mirrors, EspejoBanoLED.es provides an array of sleek and sophisticated designs that…

Author's Tranquility Press Presents: Amiss2 - A Journey of Love and Turmoil
Can Love Endure the Chaos?
Find Out in L L McCall's Riveting Sequel
Author's Tranquility Press is thrilled to unveil Amiss2, [https://www.amazon.com/Amiss2-L-McCall/dp/1964810051/ref=sr_1_1?crid=HLSE7D14EBZ4&dib=eyJ2IjoiMSJ9.nPaYbWpCIQeXuvwcUrFoE2krNynUrRc4xOci4onVMeI.klphy9Ga2a7-7htu3PLs5DVG_HRXlv0hJUjZxYzAP_8&dib_tag=se&keywords=Amiss2&qid=1736883569&s=books&sprefix=amiss2%2Cstripbooks-intl-ship%2C499&sr=1-1] the latest installment by L L McCall that delves into the deeply entangled lives of Paul and Carla. After enduring heartbreak and betrayal in their quest to rebuild their bond, the couple faces relentless challenges that test the very fabric of their love.
In Amiss2 , Paul and Carla find themselves…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…